UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802)

Bioorganic & medicinal chemistry, 2012-02, Vol.20 (3), p.1271-1280

2012

Volltextzugriff (PDF)

Stereoselective synthesis of protected (2 S,3 S)- N-methyl-5-hydroxyisoleucine, a component of halipeptins

Tetrahedron, 2004-09, Vol.60 (37), p.8031-8035

2004

Volltextzugriff (PDF)

9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors

Journal of medicinal chemistry, 2011-09, Vol.54 (18), p.6286-6294

2011

Volltextzugriff (PDF)

Total synthesis of halipeptin A, a potent anti-inflammatory cyclodepsipeptide from a marine sponge

Tetrahedron letters, 2006-02, Vol.47 (7), p.1081-1085

2006

Volltextzugriff (PDF)

Reagent-controlled diastereoselective synthesis of (2 S,3 R)- and (2 R,3 R)-2,3-diaminobutanoic acid derivatives using proline-catalyzed α-hydrazination reaction

Tetrahedron, 2009-11, Vol.65 (45), p.9468-9473

2009

Volltextzugriff (PDF)

9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5 H -benzo[ b ]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors

Journal of medicinal chemistry, 2011-09, Vol.54 (18), p.6286-6294

2011

Volltextzugriff (PDF)

Total Synthesis of Halipeptin A, a Potent Antiinflammatory Cyclodepsipeptide from a Marine Sponge

ChemInform, 2006-05, Vol.37 (22), p.no-no

2006

Volltextzugriff (PDF)

Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach

Scientific reports, 2021-10, Vol.11 (1), p.20638-20638, Article 20638

2021

Volltextzugriff (PDF)

Graph-based SLAM using architectural floor plans without loop closure

Advanced robotics, 2022-08, Vol.36 (15), p.715-723

2022

Volltextzugriff (PDF)

High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse

PloS one, 2024-08, Vol.19 (8), p.e0299760

2024

Volltextzugriff (PDF)

Localizability estimation using correlation on occupancy grid maps

ROBOMECH journal, 2023-12, Vol.10 (1), p.22-17, Article 22

2023

Volltextzugriff (PDF)

Geographic and economic influences on benralizumab prescribing for severe asthma in Japan

Scientific reports, 2024-07, Vol.14 (1), p.15190-9, Article 15190

2024

Volltextzugriff (PDF)

Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan

Scientific reports, 2023-03, Vol.13 (1), p.5208-5208, Article 5208

2023

Volltextzugriff (PDF)

Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study

BMC cancer, 2022-10, Vol.22 (1), p.1-1035, Article 1035

2022

Volltextzugriff (PDF)

Drop Head Syndrome as a Rare Complication in Mixed Connective Tissue Disease

Internal Medicine, 2020/03/01, Vol.59(5), pp.729-732

2020

Volltextzugriff (PDF)

Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor

Anticancer research, 2020-07, Vol.40 (7), p.3889-3896

2020

Volltextzugriff (PDF)

Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer

Journal of cancer research and clinical oncology, 2023-12, Vol.149 (19), p.17419-17426

2023

Volltextzugriff (PDF)

Influence of age, IGRA results, and inflammatory markers on mortality in hospitalized tuberculosis patients

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2024-01, Vol.30 (1), p.48-52

2024

Volltextzugriff (PDF)

Neural networks for separation of cosmic gamma rays and hadronic cosmic rays in air shower observation with a large area surface detector array

Machine learning: science and technology, 2024-06, Vol.5 (2), p.25016

2024

Volltextzugriff (PDF)

Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma

European clinical respiratory journal, 2024-12, Vol.11 (1), p.2384173

2024

Volltextzugriff (PDF)

Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan

Tuberculosis (Edinburgh, Scotland), 2020-12, Vol.125, p.101992-101992, Article 101992

2020

Volltextzugriff (PDF)

Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non-small cell lung carcinoma

Thoracic cancer, 2023-09, Vol.14 (25), p.2601-2607

2023

Volltextzugriff (PDF)

MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer

Thoracic cancer, 2020-10, Vol.11 (10), p.2975-2982

2020

Volltextzugriff (PDF)

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial

Thoracic cancer, 2022-01, Vol.13 (2), p.228-235

2022

Volltextzugriff (PDF)

T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

Thoracic cancer, 2021-06, Vol.12 (11), p.1726-1734

2021

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(37)
Tagungsberichte
(2)

Sprache

Englisch
(36)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(14)
Lung Cancer
(10)
Humans
(9)
Cancer Therapies
(8)
Patients
(8)
Oncology
(7)
Male
(6)
Original
(6)
Respiratory System
(6)
Technology
(6)
Adult
(5)
Biomarkers
(5)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(5)
Chemotherapy
(5)
Female
(5)
Lung Neoplasms - Drug Therapy
(5)
Lymphocytes
(5)
Multidisciplinary Sciences
(5)
Mutation
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802)

Stereoselective synthesis of protected (2 S,3 S)- N-methyl-5-hydroxyisoleucine, a component of halipeptins

9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors

Total synthesis of halipeptin A, a potent anti-inflammatory cyclodepsipeptide from a marine sponge

Reagent-controlled diastereoselective synthesis of (2 S,3 R)- and (2 R,3 R)-2,3-diaminobutanoic acid derivatives using proline-catalyzed α-hydrazination reaction

9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5 H -benzo[ b ]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors

Total Synthesis of Halipeptin A, a Potent Antiinflammatory Cyclodepsipeptide from a Marine Sponge

Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach

Graph-based SLAM using architectural floor plans without loop closure

High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse

Localizability estimation using correlation on occupancy grid maps

Geographic and economic influences on benralizumab prescribing for severe asthma in Japan

Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan

Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study

Drop Head Syndrome as a Rare Complication in Mixed Connective Tissue Disease

Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor

Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer

Influence of age, IGRA results, and inflammatory markers on mortality in hospitalized tuberculosis patients

Neural networks for separation of cosmic gamma rays and hadronic cosmic rays in air shower observation with a large area surface detector array

Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma

Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan

Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non-small cell lung carcinoma

MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial

T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

Suchergebnisse filtern